Loading...
XLONZTF
Market cap188mUSD
Dec 24, Last price  
308.00GBP
1D
-0.65%
1Q
-23.00%
Jan 2017
23.20%
Name

Zotefoams PLC

Chart & Performance

D1W1MN
XLON:ZTF chart
P/E
1,624.28
P/S
118.23
EPS
0.19
Div Yield, %
0.02%
Shrs. gr., 5y
1.15%
Rev. gr., 5y
9.40%
Revenues
127m
-0.31%
25,176,00027,975,00030,052,00031,606,00034,781,00031,816,00039,879,00044,208,00047,188,00044,634,00048,945,00053,869,00057,376,00070,146,00081,037,00080,860,00082,652,000100,750,000127,369,000126,975,000
Net income
9m
-7.64%
1,170,0002,427,0001,239,0002,918,0003,006,0002,164,0004,352,0004,497,0004,728,0003,161,0003,336,0004,824,0005,795,0006,008,0007,852,0008,217,0007,163,0004,376,00010,006,0009,242,000
CFO
8m
-63.17%
4,487,0003,197,0003,767,0004,077,0005,004,0005,808,0006,157,0004,979,0005,258,0005,596,0005,054,0007,533,0005,170,0008,732,0004,492,0008,466,00010,858,00010,897,00021,124,0007,781,000
Dividend
Sep 05, 20242.38 GBP/sh

Profile

Zotefoams plc, together with its subsidiaries, manufactures, distributes, and sells polyolefin block foams in the United Kingdom, Continental Europe, North America, and internationally. The company operates through Polyolefin Foams, High-Performance Products, and MuCell Extrusion LLC segments. It offers AZOTE, a polyolefin foam under the Plastazote, Evazote, and Supazote brands; and various high-performance foams manufactured from fluoropolymers, engineering polymers, and specialty elastomers under the ZOTEK brand. The company also provides T-FIT, a clean insulation system that is used in the pharmaceutical, biotech, and semiconductor cleanroom industries. In addition, it owns and licenses patented MuCell microcellular foam technology, as well as sells related machinery. The company primarily serves the automotive, aerospace, product protection, industrial parts, marine, building and construction, military, and sports and leisure industries. Zotefoams plc was founded in 1921 and is headquartered in Croydon, the United Kingdom.
URL
https://www.zotefoams.com/
IPO date
Feb 21, 1995
Employees
580
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
126,975
-0.31%
127,369
26.42%
100,750
21.90%
Cost of revenue
111,840
113,012
92,724
Unusual Expense (Income)
NOPBT
15,135
14,357
8,026
NOPBT Margin
11.92%
11.27%
7.97%
Operating Taxes
3,598
2,217
2,632
Tax Rate
23.77%
15.44%
32.79%
NOPAT
11,537
12,140
5,394
Net income
9,242
-7.64%
10,006
128.66%
4,376
-38.91%
Dividends
(3,350)
(3,188)
(3,074)
Dividend yield
2.01%
1.89%
1.55%
Proceeds from repurchase of equity
765
BB yield
-0.39%
Debt
Debt current
37,034
37,955
27,050
Long-term debt
2,161
908
15,353
Deferred revenue
(1)
643
Other long-term liabilities
2,656
3,290
4,657
Net debt
32,694
27,994
34,174
Cash flow
Cash from operating activities
7,781
21,124
10,897
CAPEX
(5,744)
(7,092)
(7,071)
Cash from investing activities
(8,292)
(7,092)
(6,983)
Cash from financing activities
(3,725)
(11,526)
(4,342)
FCF
1,363
9,155
5,429
Balance
Cash
6,294
10,594
8,055
Long term investments
207
275
174
Excess cash
152
4,501
3,192
Stockholders' equity
66,898
65,365
53,607
Invested Capital
156,128
146,510
141,560
ROIC
7.62%
8.43%
3.80%
ROCE
9.37%
9.27%
5.37%
EV
Common stock shares outstanding
49,805
49,539
49,334
Price
3.35
-1.47%
3.40
-15.42%
4.02
5.79%
Market cap
166,847
-0.94%
168,433
-15.07%
198,322
6.58%
EV
199,541
196,427
232,496
EBITDA
23,352
22,601
15,650
EV/EBITDA
8.54
8.69
14.86
Interest
2,540
1,738
1,046
Interest/NOPBT
16.78%
12.11%
13.03%